ENDRA Life Sciences (NDRA) Cash from Investing Activities Growth (1y) (2020 - 2026)
ENDRA Life Sciences (NDRA) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 465.38% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -1,600.38% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -2.89% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -13.29% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 32.46% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 35.74% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -91.12% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -480.95% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -353.86% |
| 10 | ENDRA Life Sciences | 5.18 Mn | 4.83 Mn | - | 2,704.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,704.17% |
| Mar 31, 2025 | 27.38% |
| Mar 31, 2024 | 11.87% |
| Dec 31, 2023 | 105.91% |
| Mar 31, 2023 | 69.78% |
| Mar 31, 2022 | -98.56% |
| Mar 31, 2021 | -101.34% |
| Dec 31, 2020 | -69.07% |
| Mar 31, 2020 | -326.61% |